EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Morphological and Immunohistochemical Characteristics of Liver Inflammation in Patients with a History of COVID-19

Ilze Strumfa iD, Ludmila Viksna iD, Oksana Kolesova iD, Ieva Vanaga iD, Haralds Plaudis iD, Jelena Storozenko, Boriss Strumfs, Janis Pavulans iD, Romans Uljanovs

Viruses · 2026

DOI: 10.3390/v18010068 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2026. Verfasst von Ilze Strumfa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Riga Stradins University, 16 Dzirciema Street, LV-1007 Riga, Latvia. Hauptthemen laut MEDLINE: COVID-19, Liver, Hepatitis. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Latvian Council of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The COVID-19 pandemic caused more than seven million deaths, mostly via acute respiratory distress syndrome with microvascular thrombosis. Compared to the amount of information about pulmonary pathology, information about COVID-19-induced liver lesions is scarce, especially with regard to the long-term consequences. The aim of our study was to evaluate inflammatory, vascular and fibrotic changes in hepatobiliary tissues of patients with a history of COVID-19 (post-COVID-19 patients). Based on the Knodell score, moderate portal inflammation was observed in 41.2% of post-COVID-19 patients, contrasting with 14.3% of control cases (p = 0.06). Moderate periportal inflammation was present in 26.5% and 7.1% of patients, respectively (p = 0.08). Post-COVID-19 patients showed higher counts of CD3+ lymphocytes (p = 0.02) and lower counts of CD68+ macrophages (p = 0.04), as well as more frequent and extensive regenerative changes in hepatocytes and the biliary epithelium (p = 0.0007). We did not find significant fibrosis or pathological changes in blood vessels, and only mild steatosis was observed in both groups.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19LiverHepatitisHumansMaleFemaleMiddle AgedImmunohistochemistryAgedSARS-CoV-2InflammationAdultMacrophagesHepatocytesAntigens, CDAntigens, Differentiation, MyelomonocyticCD68 Molecule

Stichwörter der Autor:innen

COVID-19hepatitislivermorphologyregeneration

Substanzen

Antigens, CDAntigens, Differentiation, MyelomonocyticCD68 antigen, humanCD68 Molecule

Autor:innen und Institutionen

  • Department of Pathology, Riga Stradins University, 16 Dzirciema Street, LV-1007 Riga, Latvia.
  • Department of Infectology, Riga Stradins University, 16 Dzirciema Street, LV-1007 Riga, Latvia.
  • Institute of Microbiology and Virology, Riga Stradins University, 16 Dzirciema Street, LV-1007 Riga, Latvia.
  • Department of Surgery, Riga Stradins University, 16 Dzirciema Street, LV-1007 Riga, Latvia.

ORCID-Profile: Ilze Strumfa, Ludmila Viksna, Oksana Kolesova, Ieva Vanaga, Haralds Plaudis, Janis Pavulans

Förderung

  • Latvian Council of Science

Zitieren

APA

Strumfa, I., Viksna, L., Kolesova, O., Vanaga, I., Plaudis, H., Storozenko, J., Strumfs, B., Pavulans, J., & Uljanovs, R. (2026). Morphological and Immunohistochemical Characteristics of Liver Inflammation in Patients with a History of COVID-19. Viruses. https://doi.org/10.3390/v18010068

Vancouver

Strumfa I, Viksna L, Kolesova O, Vanaga I, Plaudis H, Storozenko J, et al. Morphological and Immunohistochemical Characteristics of Liver Inflammation in Patients with a History of COVID-19. Viruses. 2026. doi:10.3390/v18010068

BibTeX
@article{Strumfa2026,
  author = {Strumfa, Ilze and Viksna, Ludmila and Kolesova, Oksana and Vanaga, Ieva and Plaudis, Haralds and Storozenko, Jelena and Strumfs, Boriss and Pavulans, Janis and Uljanovs, Romans},
  title = {Morphological and Immunohistochemical Characteristics of Liver Inflammation in Patients with a History of COVID-19},
  journal = {Viruses},
  year = {2026},
  doi = {10.3390/v18010068}
}
Kostenlos starten →